Cargando…
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
OBJECTIVE: The plasma-based methylated SEPTIN9 (mSEPT9) is a colorectal cancer (CRC) screening test for adults aged 50–75 years who are at average risk for CRC and have refused colonoscopy or faecal-based screening tests. The applicability of mSEPT9 for high-risk persons with Lynch syndrome (LS), th...
Autores principales: | Hitchins, Megan P, Vogelaar, Ingrid P, Brennan, Kevin, Haraldsdottir, Sigurdis, Zhou, Nianmin, Martin, Brock, Alvarez, Rocio, Yuan, Xiaopu, Kim, Sungjin, Guindi, Maha, Hendifar, Andrew E, Kalady, Matthew F, DeVecchio, Jennifer, Church, James M, de la Chapelle, Albert, Hampel, Heather, Pearlman, Rachel, Christensen, Maria, Snyder, Carrie, Lanspa, Stephen J, Haile, Robert W, Lynch, Henry T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577308/ https://www.ncbi.nlm.nih.gov/pubmed/31275589 http://dx.doi.org/10.1136/bmjgast-2019-000299 |
Ejemplares similares
-
Large Cancer Pedigree Involving Multiple Cancer Genes including Likely Digenic MSH2 and MSH6 Lynch Syndrome (LS) and an Instance of Recombinational Rescue from LS
por: Vogelaar, Ingrid P., et al.
Publicado: (2022) -
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
por: Haraldsdottir, Sigurdis, et al.
Publicado: (2016) -
Multiple colorectal adenomas in Lynch syndrome
por: Jain, Ayushi, et al.
Publicado: (2022) -
Pancreatic cancer ‘mismatch’ in Lynch syndrome
por: Hendifar, Andrew E, et al.
Publicado: (2019) -
Universal tumor screening for lynch syndrome on colorectal cancer biopsies impacts surgical treatment decisions
por: Vazzano, Jennifer, et al.
Publicado: (2022)